Search Results

Industry influence and Health Canada's responsibility: lessons from the opioid epidemic in Canada.

• Authors : Bavli, Itai¹ (AUTHOR)

Subjects: *DRUG labeling; *EPIDEMICS; *FRAUDCANADA

• Source: Addiction. Sep2020, Vol. 115 Issue 9, p1605-1606. 2p.

Record details

Labelling.

Subjects: *DRUG labelingCANADA; UNITED StatesEUROPEAN Union

• Source: WHO Drug Information. 2017, Vol. 31 Issue 4, p597-598. 2p.

Record details

Unauthorised Santen-brand eye drops labelled to contain a prescription drug seized in Canada.

Subjects: *EYE drops; *DRUG labeling; *DRUGSCANADA

• Source: Reactions Weekly. Aug2023, Vol. 1970 Issue 1, p10-10. 1p.

Record details

Abstracts of the 2024 Annual Conference of the Canadian Paediatric Society.

Subjects: PREVENTION of child abuse; SUBSTANCE abuse prevention; TREATMENT of eating disordersBRITISH Columbia; CANADA; HAITI

• Source: Paediatrics & Child Health (1205-7088); 2024 Supplement, Vol. 29, pe1-e51, 53p

Record details

Pharmacovigilance & Regulatory News.

Subjects: *PHARMACEUTICAL policy; *DRUG labeling; *PRODUCT recallCANADACANADA. Health Canada ; MEDICINES Co. 040861601 MEDICINES Co. MEDICINES Co. 040861601 040861601 MEDICINES Co. 040861601 MDCO; WORLD Health Organization

• Source: Reactions Weekly. 3/27/2010, Issue 1294, p2-3. 2p.

Record details

Ketalar labelling in Canada now includes hepatobiliary toxicity risk.

Subjects: *LIVER enzymes; *DRUG labeling; *LABELSCANADA

• Source: Reactions Weekly. 5/22/2021, Vol. 1856 Issue 1, p1-1. 1p.

Record details

Varenicline and buproprion: revision to consumer information.

Subjects: *NICOTINIC agonists; *DRUG labeling; *LAWCANADA

• Source: WHO Drug Information. 2013, Vol. 27 Issue 2, p109-109. 1/4p.

Record details

Rivastigmine: revised labelling warns of overdose risk.

Subjects: *DRUG labelingCANADANOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS

• Source: Reactions Weekly. 5/15/2010, Issue 1301, p4-4. 1/4p.

Record details

Unauthorised products warning in Canada.

Subjects: *DRUG labelingCANADACANADA. Health Canada

• Source: Reactions Weekly. 2/27/2010, Issue 1290, p4-4. 1/4p.

Record details

Medication incident over dual brandnames for sildenafil.

Subjects: *DRUG labeling; *DRUG information materials; *GENERIC drugsCANADACANADA. Health Canada

• Source: Reactions Weekly. 10/24/2009, Issue 1275, p2-2. 1/3p.

Record details